查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405896

臨床實驗室測試市場規模、佔有率和趨勢分析報告：按類型、最終用途、按地區、細分市場預測，2024-2030 年

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/HCT Testing), By End-use (Primary Clinics, Central Laboratories), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 104 Pages | 商品交期: 2-10個工作天內

價格

臨床實驗室測試市場成長和趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球臨床實驗室檢測市場規模預計將達到2,130.4億美元，2024年至2030年複合年成長率為9.2%。

臨床實驗室檢測市場的成長歸因於目標疾病盛行率的上升。由於將測試用於多種診斷目的，臨床實驗室測試的使用正在增加，主要關注患者的健康狀況，從而評估和製定適當的診斷和治療。

世界人口老化不斷增加，被認為是心血管疾病和腎功能障礙等疾病發展的最大危險因子。據世界衛生組織稱，到2030年，60歲及以上的人口預計將達到六分之一，從2020年的10億增加到2030年的14億。此外，到2050年，80歲及以上的人口預計將增加一倍，達到15億以上，80歲及以上的人口預計將增加兩倍，達到4,260億。因此，預計老年人口的增加將在預測期內成為市場的一個有影響力的市場驅動力。

心血管疾病和糖尿病等目標疾病盛行率的增加預計將在整個預測期內提振市場。 CVD 是致命的，也是全世界死亡的主要原因。與心血管疾病相關的大量未滿足的醫療需求以及相關的患者意識的提高是預計推動床邊血脂檢測需求的因素之一。根據世界衛生組織統計，2021年，心血管疾病是過去30年來全球死亡和發病的主要原因，每年有177億人死於心血管疾病，佔17億人的31%。

此外，參與臨床診斷藥物開發和配製的主要公司正在專注於合作研究和夥伴關係，以開發新的結核病治療方法並保持市場競爭力。此外，預計實驗室自動化系統的日益採用也將在預測期內推動市場發展。例如，2023年1月，BD推出了第三代整體實驗室自動化系統，可實現微生物實驗室檢體處理的自動化。此外，2023 年 1 月，NovoPath LLC 擴展了其針對腫瘤實驗室的 LIS 解決方案。

臨床實驗室檢測市場報告亮點

  • HbA1c 測試領域在 2023 年佔據最大的銷售佔有率，這是由於糖尿病人口不斷增加。
  • 由於血液相關疾病的盛行率不斷增加，預計 HGB/HCT 檢測領域在預測期內將呈現最快的成長速度。
  • 由於市場普及和檢測量較高，中心實驗室領域將在 2023 年佔據市場主導地位。
  • 由於監管支持的不斷增加和臨床測試投資的增加，北美在 2023 年佔據了最大的市場佔有率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章臨床實驗室檢測市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 臨床實驗室測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章臨床實驗室檢測市場：類型估計和趨勢分析

  • 類型市場佔有率，2023 年和 2030 年
  • 細分儀表板
  • 按類型分類的全球臨床實驗室檢測市場展望
  • 2018年至2030年市場規模、預測與趨勢分析如下
    • 血液常規檢查
    • HGB/HCT測試
    • 基礎代謝小組測試
    • BUN 肌酸酐測試
    • 電解質測試
    • 糖化血紅素測試
    • 2018-2030 年市場估計與預測
    • 綜合代謝組測試
    • 肝臟檢測
    • 腎臟組合測試
    • 血脂檢查
    • 心血管小組測試

第5章臨床實驗室檢測市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的全球臨床實驗室檢測市場展望
  • 2018年至2030年市場規模、預測與趨勢分析如下
    • 中心實驗室
    • 基層診所

第6章臨床實驗室檢測市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
  • 供應商形勢
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023 年主要企業股票分析
    • Abbott
    • CINVEN
    • QUEST DIAGNOSTICS INCORPORATED
    • OPKO HEALTH, INC.
    • F. Laboratory Corporation of America Holdings
    • UNILABS
    • Synnovis Group LLP
    • SONIC HEALTHCARE
Product Code: 978-1-68038-361-4

Clinical Laboratory Tests Market Growth & Trends:

The global clinical laboratory tests market size is expected to reach USD 213.04 billion by 2030, expanding at a CAGR of 9.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

Clinical Laboratory Tests Market Report Highlights:

  • HbA1c tests segment held largest revenue share in 2023 and is attributable to the increasing prevalence of diabetic population
  • HGB/HCT tests segment is expected to show fastest growth rate over the forecast period owing to the growing prevalence of blood-related disorders
  • Central laboratories segment dominated the market in 2023 attributable to the high market penetration and procedure volumes
  • North America held the largest market share in 2023 which can be attributed to the growing regulatory support and increase in investments in clinical laboratory tests

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Laboratory Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Growing prevalence of target disease
      • 3.2.1.3. Introduction of innovative solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of ambiguous regulatory framework
      • 3.2.2.2. COVID-19 pandemic
  • 3.3. Clinical Laboratory Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Laboratory Tests Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Complete Blood Count
      • 4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. HGB/HCT Testing
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.3. Basic Metabolic Panel Testing
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.4. BUN Creatinine Testing
      • 4.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.5. Electrolytes Testing
      • 4.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.6. HbA1c Testing
    • 4.4.7. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.8. Comprehensive Metabolic Panel Testing
      • 4.4.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.9. Liver Panel Testing
      • 4.4.9.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.2. Hepatitis
      • 4.4.9.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.3. Bile Duct Obstruction
      • 4.4.9.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.4. Liver Cirrhosis
      • 4.4.9.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.5. Liver Cancer
      • 4.4.9.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.6. Bone Disease
      • 4.4.9.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.7. Autoimmune Disorders
      • 4.4.9.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.8. Others
      • 4.4.9.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.10. Renal Panel Testing
      • 4.4.10.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.11. Lipid Panel Testing
      • 4.4.11.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.12. Cardiovascular Panel Testing
      • 4.4.12.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Laboratory Tests Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Central Laboratories
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 5.4.2. Primary Clinics
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. CINVEN
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. QUEST DIAGNOSTICS INCORPORATED
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. OPKO HEALTH, INC.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. F. Laboratory Corporation of America Holdings
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. UNILABS
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Synnovis Group LLP
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. SONIC HEALTHCARE
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 3 North America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 4 North America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 5 U.S. clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 Canada clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Europe clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 10 Europe clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Europe clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 Germany clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 UK clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 France clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 18 Italy clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Spain clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 Denmark clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Denmark clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Sweden clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Sweden clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26 Norway clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Norway clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 31 China clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Japan clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35 India clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 South Korea clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 38 South Korea clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Australia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Australia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Thailand clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 42 Thailand clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America clinical laboratory tests market, by application, 2018 - 2030 (USD Billion)
  • Table 46 Brazil clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 MEA clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 53 MEA clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 54 MEA clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 South Africa clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 59 UAE clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 60 UAE clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Clinical laboratory tests market: market outlook
  • Fig. 14 Clinical laboratory tests competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical laboratory tests market driver impact
  • Fig. 20 Clinical laboratory tests market restraint impact
  • Fig. 21 Clinical laboratory tests market strategic initiatives analysis
  • Fig. 22 Clinical laboratory tests market: Type movement analysis
  • Fig. 23 Clinical laboratory tests market: Type outlook and key takeaways
  • Fig. 24 CBC market estimates and forecast, 2018 - 2030
  • Fig. 25 HGB/HCT test market estimates and forecast, 2018 - 2030
  • Fig. 26 Basic metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 27 BUN creatinine test market estimates and forecast, 2018 - 2030
  • Fig. 28 Electrolyte tests market estimates and forecast, 2018 - 2030
  • Fig. 29 HbA1c tests market estimates and forecast, 2018 - 2030
  • Fig. 30 Comprehensive metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 31 Liver panel test market estimates and forecast, 2018 - 2030
  • Fig. 32 Hepatitis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 33 Bile duct obstruction liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 34 Liver cirrhosis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 35 Liver cancer liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 36 Bone disease liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 37 Autoimmune disorders liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 38 Others liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 39 Renal panel test market estimates and forecast, 2018 - 2030
  • Fig. 40 Lipid panel tests market estimates and forecast, 2018 - 2030
  • Fig. 41 Cardiovascular panel test market estimates and forecast, 2018 - 2030
  • Fig. 42 Clinical laboratory tests market: End-use movement Analysis
  • Fig. 43 Clinical laboratory tests market: End-use outlook and key takeaways
  • Fig. 44 Central Laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 45 Primary Clinics market estimates and forecasts,2018 - 2030
  • Fig. 46 Global clinical laboratory tests market: Regional movement analysis
  • Fig. 47 Global clinical laboratory tests market: Regional outlook and key takeaways
  • Fig. 48 Global clinical laboratory tests market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America: SWOT
  • Fig. 55 Europe SWOT
  • Fig. 56 Asia Pacific SWOT
  • Fig. 57 Latin America SWOT
  • Fig. 58 MEA SWOT
  • Fig. 59 North America, by country
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 66 Europe
  • Fig. 67 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 68 UK
  • Fig. 69 UK market estimates and forecasts, 2018 - 2030
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 72 France
  • Fig. 73 France market estimates and forecasts, 2018 - 2030
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 78 Denmark
  • Fig. 79 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 80 Sweden
  • Fig. 81 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 82 Norway
  • Fig. 83 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 84 Asia Pacific
  • Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 86 China
  • Fig. 87 China market estimates and forecasts, 2018 - 2030
  • Fig. 88 Japan
  • Fig. 89 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 90 India
  • Fig. 91 India market estimates and forecasts, 2018 - 2030
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 94 South Korea
  • Fig. 95 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 96 Australia
  • Fig. 97 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 98 Latin America
  • Fig. 99 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 100 Brazil
  • Fig. 101 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 102 Mexico
  • Fig. 103 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 104 Argentina
  • Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 106 Middle East and Africa
  • Fig. 107 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 South Africa
  • Fig. 109 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 110 Saudi Arabia
  • Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 112 UAE
  • Fig. 113 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 116 Market share of key market players- Clinical laboratory tests market